Evaluation of Ki-67 staining (MFI) revealed that gefitinib was only able to impair APL cell proliferation at concentrations > 40 μM in NB4 and NB4-R2 cells (Figures 2E–H). The gene discussed is MKI67; the disease is acute promyelocytic leukemia.